Erythropoetic-stimulating agents: where do we stand?
Dicato
M
M
Hematology-Oncology Service, Centre Hospitalier, Luxembourg.
D006397:Hematinics / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000628:therapy; D017410:Practice Guidelines as Topic; D013923:Thromboembolism / Q000139:chemically induced
D006397:Hematinics